A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metast ...
Sep 29, 2014
not rated yet | 0
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.
Sep 25, 2014
5 / 5 (1) | 0